2001 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Kelsen
    Kelsen
  4. Saltz
    Saltz
  5. Norton
    Norton
  6. Bajorin
    Bajorin
  7. Kemeny
    Kemeny
  8. Scher
    Scher
  9. Ilson
    Ilson
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1218)
  2. Solid Tumor Oncology Division (929)
  3. Survivorship Research (432)
  4. Surgery (399)
  5. Hematologic Malignancies, Division of (340)
  6. Center for Hematologic Malignancies (328)
  7. Gastrointestinal Oncology Service (315)
  8. Epidemiology and Biostatistics (251)
  9. Genitourinary Oncology Service (233)
  10. Biostatistics Service (223)
  1. "antineoplastic combined chemotherapy protocols"
Formats
  1. Journal Article (1861)
  2. Conference Paper (49)
  3. Review (39)
  4. Editorial (17)
  5. Research Letter (15)
  6. Miscellaneous (8)
  7. Correspondence (6)
  8. Guidelines (5)
  9. Book Section (1)
Groups
  1. Department of Medicine (1218)
  2. Solid Tumor Oncology Division (929)
  3. Survivorship Research (432)
  4. Surgery (399)
  5. Hematologic Malignancies, Division of (340)
  6. Center for Hematologic Malignancies (328)

More Groups

People
  1. Nancy Kemeny (90)
  2. Robert Motzer (88)
  3. Clifford Hudis (83)
  4. David Kelsen (83)
  5. Leonard Saltz (79)
  6. Larry Norton (77)

More People

Years
  1. 2025 (46)
  2. 2024 (133)
  3. 2023 (122)
  4. 2022 (90)
  5. 2021 (11)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (279)
  2. Cancer (171)
  3. Clinical Cancer Research (78)
  4. Seminars in Oncology (59)
  5. Gynecologic Oncology (58)
  6. New England Journal of Medicine (58)

More Publications

Publishers
  1. American Society of Clinical Oncology (294)
  2. Elsevier Inc. (276)
  3. Wiley Blackwell (212)
  4. Springer (167)
  5. Oxford University Press (113)
  6. American Association for Cancer Research (108)

More Publishers

Results (2001)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization and management of adverse reactions in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab
    Journal Article

    Colombo, N.; Lorusso, D.; Monk, B. J.; Slomovitz, B.; Hasegawa, K.; Nogueira-Rodrigues, A.; Zale, M.; Okpara, C. E.; Barresi, G.; McKenzie, J.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • SKYSCRAPER-02: Tiragolumab in combination with atezolizumab plus chemotherapy in untreated extensive-stage small-cell lung cancer
    Journal Article

    Rudin, C. M.; Liu, S. V.; Soo, R. A.; Lu, S.; Hong, M. H.; Lee, J. S.; Bryl, M.; Dumoulin, D. W.; Rittmeyer, A.; Chiu, C. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Negative hyperselection of patients with HER2(+) and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: The PRESSING-HER2 study
    Journal Article

    Randon, G.; Nakamura, Y.; Yaeger, R.; Lonardi, S.; Cremolini, C.; Elez, E.; Nichetti, F.; Ghelardi, F.; Nasca, V.; Bergamo, F.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)
    Journal Article

    Movva, S.; Matloob, S.; Handorf, E. A.; Choy, E.; Merriam, P.; Flieder, D. B.; Cai, K. Q.; Zhou, Y.; Tetzlaff, E. D.; Pagan, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Gemcitabine with cisplatin versus hepatic arterial infusion pump chemotherapy for liver-confined unresectable intrahepatic cholangiocarcinoma
    Miscellaneous

    Franssen, S.; Holster, J. J.; Jolissaint, J. S.; Nooijen, L. E.; Cercek, A.; D'Angelica, M. I.; Homs, M. Y. V.; Wei, A. C.; Balachandran, V. P.; Drebin, J. A.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Compliance and toxicity of total neoadjuvant therapy for rectal cancer: A secondary analysis of the OPRA trial
    Journal Article

    Verheij, F. S.; Omer, D. M.; Lin, S. T.; Yuval, J. B.; Thompson, H. M.; Kim, J. K.; Valdivieso, S. C.; Qin, L. X.; Wu, A. J.; Saltz, L. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Rebuttal to comment on “concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer”
    Correspondence

    Han, J. E.; Zakeri, K.; Michel, L.; Sherman, E. J.; Lee, N. Y.
    Head & Neck (2024)

    Fulltext@MSK | Save
  • Great debate: Chemoradiation should be added to chemotherapy as a neoadjuvant treatment strategy for resectable gastric adenocarcinoma
    Editorial

    Daniel, S. K.; Badgwell, B. D.; McKinley, S. K.; Strong, V. E.; Poultsides, G. A.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Gemcitabine with cisplatin versus hepatic arterial infusion pump chemotherapy for liver-confined unresectable intrahepatic cholangiocarcinoma
    Journal Article

    Franssen, S.; Holster, J. J.; Jolissaint, J. S.; Nooijen, L. E.; Cercek, A.; D’Angelica, M. I.; Homs, M. Y. V.; Wei, A. C.; Balachandran, V. P.; Drebin, J. A.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save